NCT02514122View on ClinicalTrials.gov

Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Post Operative PainPain
Interventions
DRUG

Ketamine

Patients will receive a subcutaneous injection of ketamine (at a dose of 1mg/kg) immediately following surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections.

DRUG

Saline

Patients will receive a subcutaneous injection of saline (at a dose of 0.02cc/kg) immediately following surgery, the evening after surgery, and every 12 hours thereafter for a total of 5 injections.

Trial Locations (1)

S7N 0W8

University of Rwanda, Kigali

All Listed Sponsors
collaborator

National University, Rwanda

OTHER

lead

University of Saskatchewan

OTHER

NCT02514122 - Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda | Biotech Hunter | Biotech Hunter